Clinical Trials Browser

Phase 1/2 × denileukin diftitox × 1 year × Clear all

NCT05200559 2026-05-29

T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Turcot syndrome, Carcinoma, Ovarian Epithelial